Neural Regeneration Research ›› 2015, Vol. 10 ›› Issue (9): 1381-1382.doi: 10.4103/1673-5374.165222

Previous Articles     Next Articles

 Adipose-brain crosstalk: do adipokines have a role in neuroprotection?

Jonathan P. Little, Adeel Safdar   

  1. School of Health and Exercise Sciences, University of British Columbia Okanagan, Kelowna, BC, Canada, V1V 1V7 (Little JP)
    Departments of Pediatrics and Medicine, McMaster University, Hamilton, ON, Canada, L8S 4K1 (Safdar A)
  • Received:2015-06-15 Online:2015-09-28 Published:2015-09-28
  • Contact: Jonathan P. Little, Ph.D., jonathan.little@ubc.ca.

Abstract:

Accumulating evidence from epidemiological and experimental studies indicate that obesity, and its related metabolic consequences of insulin resistance and type 2 diabetes, are associated with accelerated cognitive decline. The etiology of neurodegeneration in obesity is undoubtedly complex, with vascular, metabolic, inflammatory, and structural changes all likely to play a role. The discovery of leptin in 1994 and the subsequent advancement in our understanding that adipose tissue is an endocrine organ that can communicate with the brain to regulate appetite brings about the intriguing possibility that adipose-brain crosstalk could be involved in obesity-related neurodegeneration. Indeed neurons have been shown to express receptors for various adipokines, indicating that factors released from adipose tissue have the potential to communicate directly with the brain. Research in this area is relatively new, but some intriguing new studies highlight that the secretory profile of adipose tissue might be involved in maintenance of neuronal viability.